Mammographic BAC data can flag women at risk of heart disease

Wednesday, December 2 | 9:30 a.m.- 10:30 a.m. | W3-SSCA07-8 | Room E353C

Mammographic breast arterial calcification (BAC) data shows promise for identifying women at increased risk of valvular heart disease (VHD), according to this talk.

The finding could translate to earlier heart health assessment without additional imaging or cost, according to presenter Theodorus Dapamede, MD, PhD, of Emory University in Atlanta, GA.

Dapamede and colleagues explored whether BAC data could independently predict incident VHD -- including aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, and tricuspid regurgitation. The team conducted a study that included 120,892 women from two U.S. healthcare systems; it quantified BAC on screening mammography as zero, mild, moderate, or severe and identified incident VHD from post-mammography echocardiography.

The group reported the presence of BAC in 20.8%of women and incident VHD in 2.5% over median follow-up of 6.3 years. It also found associations between BAC and aortic stenosis (Concordance index, or C-index, of 0.854); aortic regurgitation (C-index 0.777); mitral stenosis (C-index 0.790); and tricuspid regurgitation (C-index 0.797) across mild, moderate, and severe BAC categories. The team noted that "mitral stenosis was the sole subtype not significantly associated with BAC."

The takeaway? "The singular exemption of mitral stenosis, a lesion predominantly of rheumatic rather than degenerative etiology, highlights the mechanistic specificity of BAC as a marker of calcific valvular disease," the authors wrote.

Sit in on this talk to get all of the details.

Page 1 of 2
Next Page